The Wisconsin DNR approved permits for Enbridge to reroute Line 5. Here are the next steps in the controversial project.

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

The third-quarter earnings season came to an end this week for large drugmakers, with AstraZeneca AZN and Bayer BAYRY ...

Elite Pharmaceuticals, Inc. ( OTCQB:ELTP) Q2 2025 Earnings Conference Call November 15, 2024 11:30 AM ET Nasrat Hakim - President and CEO Carter Ward - CFO ...

Ola Electric has confirmed the launch of an electric three-wheeler in the first or second quarter of the upcoming financial ...

A slow launch for Alzheimer's medicine Leqembi, a lackluster pipeline and a challenging drug launch environment are just a ...

According to the report, the Abu Dhabi market is well-positioned for growth, driven by new developers entering the market and ...

Has something changed regarding Eli Lilly or Regeneron's thesis, or is the recent dip an excellent opportunity to invest in ...

Updated figures provided through the department’s Urban Development Program (UDP) show completions are down 18 per cent on the five-year average. Loading Developer lobby group Urban Taskforce ...

When I was young man, I met a girl in Tennessee who turned out to be a moonshiner’s daughter. That was a long time ago. But I ...

Got $5,000? These 5 High-Yield Dividend Stocks Could Turn It Into More Than $300 of Annual Passive Income.

Submitted New Drug Application (NDA) to FDA for TNX-102 SL for fibromyalgia based on two statistically significant Phase 3 studiesGranted Fast ...